- Home
- MUSA vs AXSM Comparison
MUSA vs AXSM Comparison
Compare MUSA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MUSA | AXSM |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | 16900 | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.0B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MUSA | AXSM |
|---|---|---|
| Price | $504.48 | $156.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 17 |
| Target Price | ★ $458.43 | $210.65 |
| AVG Volume (30 Days) | 343.9K | ★ 481.9K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ 24.10 | N/A |
| Revenue | ★ $21,529,400,000.00 | N/A |
| Revenue This Year | $17.24 | $58.18 |
| Revenue Next Year | $3.49 | $55.45 |
| P/E Ratio | $20.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $345.23 | $86.99 |
| 52 Week High | $523.09 | $191.50 |
Technical Indicators
Market Signals| Indicator | MUSA | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 74.06 | 40.92 |
| Support Level | $357.92 | $150.75 |
| Resistance Level | N/A | $169.11 |
| Average True Range (ATR) | 15.39 | 4.57 |
| MACD | 4.43 | 0.69 |
| Stochastic Oscillator | 99.99 | 28.11 |
Price Performance
Historical ComparisonAbout MUSA Murphy USA Inc.
Murphy USA Inc is mainly engaged in the marketing of retail motor fuel products and convenience merchandise through a network of several retail stores in the Southwest, Southeast, Midwest, and Northeast United States. The majority of Murphy USA's stores are located in proximity to Walmart Supercenters, but it also operates standalone stores that market gasoline and other products under the Murphy USA, Murphy Express, and QuickChek brands. In addition, the company also markets fuel to unbranded wholesale customers through a mixture of company-owned and third-party product distribution terminals and pipeline positions. The firm generates maximum revenue through retail sales of petroleum products, and the rest from merchandise sales and wholesale of petroleum products.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.